Stocks News

LAST PRICE
104.3600
TODAY'S CHANGE (%)
Trending Down-0.7000 (-0.6663%)

Bid / Lots
104.3500/ 7
Ask / Lots
104.3700/ 5
Open / Previous Close
105.3100 / 105.0600
Day Range
Low 104.0001
High 105.9200
52 Week Range
Low 94.7313
High 148.1500
Volume
2,982,908
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Novo Nordisk A/S Stock Falls Monday, Underperforms Market, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: NVO
  
  This article was automatically generated using Dow Jones technology.
  
  Shares of Novo Nordisk A/S slid 0.7% to DKK745.40 Monday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.2% to 2,609.69.
- Novo Nordisk to Buy Norwegian Fish Genetics Firm Benchmark Genetics, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: NVO
  11:25 AM EST, 11/25/2024 (MT Newswires) -- Novo Nordisk (NVO) said Monday it has agreed to buy Benchmark Genetics, a Norwegian fish genetics company, from Benchmark Holdings for up to 260 million British pounds ($326.5 million). Benchmark Genetics s...
- Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: NVO, CTLT
  07:53 AM EST, 11/25/2024 (MT Newswires) -- Novo Nordisk's (NVO) parent company, Novo Holdings, is expected to win EU antitrust approval for its pending $16.5 billion acquisition of US contract drug maker Catalent (CTLT), Reuters reported Friday, cit...
Nov 22, 2024
- DJ The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO, AMGN
  
  By Jacob Sonenshine
  
  Stocks of anti-obesity drugmakers Eli Lilly, Novo Nordisk, and Amgen have gotten hit as the market frets over what a Robert F. Kennedy Jr.-run Department of Health and Human Services would mean for the group. The worries are overblown, and investors should use the selloff to scoop the stocks up on the cheap.
- DJ Novo Nordisk A/S Stock Rises Friday, Outperforms Market, from 12:03PM ET on Friday Nov 22, 2024 by Dow Jones
  12:03PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: NVO
  
  This article was automatically generated using Dow Jones technology.
  
  Shares of Novo Nordisk A/S rose 4.0% to DKK750.90 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 2.0% to 2,615.49.

Today
- Sector Update: Health Care Stocks Edge Higher Premarket Monday, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: IBB, SAVA, XLV, ALNY, BHVN
- Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: ALNY
- Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: NVO, CTLT
- Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: ALNY
Nov 22, 2024
- DJ Jazz Pharmaceuticals Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 4:42AM ET on Friday Nov 22, 2024 by Dow Jones
  4:42AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: JAZZ
Nov 21, 2024
- DJ Jazz Pharmaceuticals Price Target Maintained With a $207.00/Share by Needham, from 1:06PM ET on Thursday Nov 21, 2024 by Dow Jones
  1:06PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: JAZZ
- DJ Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK, from 9:30AM ET on Thursday Nov 21, 2024 by Dow Jones
  9:30AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: JAZZ, ZYME, BGNE
- Sector Update: Health Care Stocks Rise Pre-Bell Thursday, from 9:13AM ET on Thursday Nov 21, 2024 by MT Newswires
  9:13AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: IBB, JAZZ, PFE, XLV, ZYME, ZLAB, NRIX
- DJ Jazz Pharmaceuticals Price Target Cut to $163.00/Share From $166.00 by Piper Sandler, from 9:06AM ET on Thursday Nov 21, 2024 by Dow Jones
  9:06AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: JAZZ
- Sector Update: Health Care, from 8:52AM ET on Thursday Nov 21, 2024 by MT Newswires
  8:52AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: JAZZ, ZYME

Novo Nordisk A/S
NYSE:NVOUnited States

Search Criteria

Today

DJ Novo Nordisk A/S Stock Falls Monday, Underperforms Market, from 2 hours ago by Dow Jones

Novo Nordisk to Buy Norwegian Fish Genetics Firm Benchmark Genetics, from 2 hours ago by MT Newswires

Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 6 hours ago by MT Newswires

Nov 22, 2024

DJ The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones

DJ Novo Nordisk A/S Stock Rises Friday, Outperforms Market, from 12:03PM ET on Friday Nov 22, 2024 by Dow Jones

Peers Headlines

Today

Sector Update: Health Care Stocks Edge Higher Premarket Monday, from 5 hours ago by MT Newswires

Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy, from 6 hours ago by MT Newswires

Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 6 hours ago by MT Newswires

Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy, from 7 hours ago by Dow Jones

Nov 22, 2024

DJ Jazz Pharmaceuticals Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 4:42AM ET on Friday Nov 22, 2024 by Dow Jones

Nov 21, 2024

DJ Jazz Pharmaceuticals Price Target Maintained With a $207.00/Share by Needham, from 1:06PM ET on Thursday Nov 21, 2024 by Dow Jones

DJ Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK, from 9:30AM ET on Thursday Nov 21, 2024 by Dow Jones

Sector Update: Health Care Stocks Rise Pre-Bell Thursday, from 9:13AM ET on Thursday Nov 21, 2024 by MT Newswires

DJ Jazz Pharmaceuticals Price Target Cut to $163.00/Share From $166.00 by Piper Sandler, from 9:06AM ET on Thursday Nov 21, 2024 by Dow Jones

Sector Update: Health Care, from 8:52AM ET on Thursday Nov 21, 2024 by MT Newswires